附录

Author guidelines: Volume 5 Issue 1

• 抽象的

附录

Indices: Volume 5 Issue 1

• 抽象的

附录

Glossary: Volume 5 Issue 1

• 抽象的

附录

Bulletin board: Volume 5 Issue 1

• 抽象的

附录

Acknowledgment: Volume 5 Issue 1

• 抽象的

评论文章

Eating disorders related to obesity

Varsha Vaidya and Abdul Malik

• 抽象的

评论文章

Hyperbaric oxygen therapy in the management of nonhealing wounds in patients with critical limb ischemia

Gunalp Uzun, Senol Yildiz and Samil Aktas

• 抽象的

药物评价

Recombinant human epoetin beta in the treatment of renal anemia

Lucia Del Vecchio Andrea Cavalli, Pietro Pozzoni and Francesco Locatelli

• 抽象的

药物评价

Vildagliptin: novel pharmacological approach to treat Type 2 diabetes

Bo Ahraain

• 抽象的

评论文章

Osteoclast-targeted therapy for metastatic prostate cancer

Richard J Lee and Matthew R Smith

• 抽象的

评论文章

Castrate-resistant prostate cancer: the right targets and combinations

Joyson Karakunnel and William Dahut

• 抽象的

评论文章

New directions in endocrine therapy: renewed interest in the androgen receptor

Zoran Culig and Alfred Hobisch

• 抽象的

评论文章

Salvage cryotherapy for recurrent prostate cancer after radiation failure: current status and future perspectives

Mohamed Ismail, Pandha Hardev and John Davies

• 抽象的

看法

Avoiding surgery in prostate cancer patients with low-risk disease

Vladimir Mouraviev andThomas J Polascik

• 抽象的

面试

Dr Charles Drake speaks to Laura Dormer, Editor

Charles Drake

• 抽象的

新闻与观点

Focus on novel approaches in prostate cancer therapy

• 抽象的

研究亮点

Highlights from the latest papers in prostate cancer research

Yaacov Richard Lawrence and Adam P Dicker

• 抽象的

社论

TGF-β signaling dictates therapeutic targeting in prostate cancer

Natasha Kyprianou

• 抽象的

社论

Therapeutic vaccines for prostate cancer: what have we learned?

James L Gulley

• 抽象的

前言

Novel approaches for the treatment of prostate cancer

Philip M Arlen

• 抽象的